GLOBAL DRO – To check any medication

The Global Drug Reference Online (Global DRO) provides athletes and support personnel with information about the prohibited status of specific medications based on the current World Anti-Doping Agency (WADA) Prohibited List.To Check Your Medications:

Click the Global DRO Banner/Image below to go to the Global DRO Website, you can then enter any medication to see if it is on a banned substance list, follow these instructions below when you have clicked through.

• USER TYPE > Athlete
• SPORT > Darts (WDF)
• NATION OF PURCHASE > UK (unless from outside uk)
• ADD YOUR MEDICATION NAME > Click Search
• TERMS & CONDITIONS > Click Accept
• TOTAL RESULTS > Pick Which One

CLICK BELOW > > >

Global DRO does not contain information on, or that applies to, any dietary supplements. Visitors can search the Global DRO for specific information on products sold in the United Kingdom, Canada, the United States and Japan.

Statement on supplements:

Supplement products are not on WADA list of prohibited substances per se. Nevertheless, we suggest all players be wary about taking supplements as they sometimes contain ingredients which are not apparent or easily spotted and which might be (alone or in combination with other ingredients) prohibited. Players need to be aware that they take supplements entirely on their own risk: this is also UKAD’s position on supplements.

Global DRO is brought to you through a partnership between UK Anti-Doping (UKAD), the Canadian Centre for Ethics in Sport (CCES) and the United States Anti-Doping Agency (USADA). The Japan Anti-Doping Agency (JADA) is an official Global DRO licensee.

*IMPORTANT INFORMATION RE BETA BLOCKERS*

Circular
 – Drug Testing in Darts Update on Beta Blockers

• 1 – Below is the official announcement by the DRA on Beta Blockers
• 2 – The DRA Rule 7.1.2 (ii)
• 3 – User friendly terms of what this means for members

1- Since 6th January 2019 unapproved use of Beta-Blockers has been subject to disciplinary rules (as then amended).

Given the complexity of processing Therapeutic Use Exemption Applications and other technical procedures required which flow from these rule changes, the DRA has been in detailed communication with UK Anti-Doping (UKAD) to implement these changes. Unfortunately, we have been unable to finalise our procedures with UKAD and this has proved more difficult than originally anticipated. Accordingly, and so that testing can continue the DRA Board of Directors has made the following decision:

The application of section 7.1.2 (ii) of the DRA Rules is suspended until further notice. Please note that this suspension does not affect your obligation to inform the DRA if you are currently prescribed Beta-Blockers. It also does not affect your obligations in respect of other medications and TUEs.

We remind all players that it is your responsibility to have any medication you use checked to see if it or any of its ingredients are prohibited. If any player is unsure or has any questions regarding any medications (including Beta-Blockers), please contact us using the email addresses or a telephone number below.

You can also check your medication on the Global DRO website: CLICK HERE

If you need any further assistance or help, please contact us using the following email addresses: timo@moore-tibbits.co.uk and monikak@moore-tibbits.co.uk Alternatively, you can speak to Tim Ollerenshaw or Monika Krtenova using this following telephone number +44(0)1926 674544 – Dated 3rd June 2019

2 – DRA Rule 7.1.2 (ii)

(ii) the unauthorised use by a Player of Beta-Blockers [in or out of competition] for incidents occurring on or after 6th January 20191;

3 – What does this mean

NOTE a
Players will still need to check all Medications and will still need a TUE Certificate for all prohibited substances/medications.

NOTE b
If a player is on Beta Blockers, they are obliged to inform the DRA but can use this medication with a TUE form, We do not recommend their using Beta-Blockers, if there is an alternative medication available, but it will not be treated as a Disciplinary matter currently, if they are tested and found to have Beta-Blockers in their system.

They do not need a TUE Form for Beta-Blockers now as there is currently no procedure in place to deal with Beta-Blockers TUE Forms (this will obviously change once such a procedure has been adopted). At the moment, their only obligation in respect of Beta-Blockers is to inform the DRA.

If you have any issues, comments or queries please refer to the above correspondence or contact your PDPA